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Abstract
Background: The REtirement in ACTion (REACT) study is a multi-centre, pragmatic, two-arm, parallel-group randomised
controlled trial (RCT) with an internal pilot phase. It aims to test the effectiveness and cost-effectiveness of a community,
group-based physical activity intervention for reducing, or reversing, the progression of functional limitations in older
people who are at high risk of mobility-related disability.
Methods/design: A sample of 768 sedentary, community-dwelling, older people aged 65 years and over with functional
limitations, but who are still ambulatory (scores between 4 and 9 out of 12 in the Short Physical Performance Battery test
(SPPB)) will be randomised to receive either the REACT intervention, delivered over a period of 12 months by trained
facilitators, or a minimal control intervention. The REACT study incorporates comprehensive process and economic
evaluation and a nested sub-study which will test the hypothesis that the REACT intervention will slow the rate of
brain atrophy and of decline in cognitive function assessed using magnetic resonance imaging (MRI). Outcome data
will be collected at baseline, 6, 12 and 24 months for the main study, with MRI sub-study data collected at baseline, 6
and 12 months.
The primary outcome analysis (SPPB score at 24 months) will be undertaken blinded to group allocation. Primary
comparative analyses will be on an intention-to-treat (ITT) basis with due emphasis placed on confidence intervals.
Discussion: REACT represents the first large-scale, pragmatic, community-based trial in the UK to target the non-disabled
but high-risk segment of the older population with an intervention to reduce mobility-related disability. A programme
that can successfully engage this population in sufficient activity to improve strength, aerobic capacity, coordination and
balance would have a major impact on sustaining health and independence.
REACT is also the first study of its kind to conduct a full economic and comprehensive process evaluation alongside the
RCT. If effective and cost-effective, the REACT intervention has strong potential to be implemented widely in the UK and
elsewhere.
(Continued on next page)
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Background
During old age, there is a population-wide transition
from independence and adequate physical function
towards frailty and an increased demand for health and
social care support services. In particular, the prevalence
of mobility-related disability increases rapidly with age
[1]. Frailty and associated co-morbidities compromise
quality of life for older adults and contribute major soci-
etal costs; directly to people who live with frailty, to
friends and family providing care and losing productivity,
and to health and social care services [2, 3].
Physical inactivity is one of the strongest predictors of
mobility-related disability in older adults [4]. A fit and
active older person has a 36% lower risk of developing
functional limitations and a 38% lower risk of hip fracture
[5]. In the UK-based Opal Plus cohort, older people who
undertook at least an average of 25 min of moderate to
vigorous physical activity (MVPA) per day at baseline
received fewer prescriptions and were less likely to be
admitted to hospital in an emergency 4 to 5 years later [6].
Clinical trials have provided robust evidence that phys-
ical features of frailty, such as reduced muscular strength
or endurance, can be reversed, or at least the progression
of these frailty indicators can be slowed, by undertaking
an appropriate exercise programme [7, 8]. Unfortunately,
older adults are the least active segment of the UK popula-
tion. Less than 30% of 65–74-year-olds report any
moderate-intensity physical activity lasting at least 10 min
in the previous 4 weeks [9]. Health Survey for England
(HSE) data indicate that among people aged 65 years and
above, 36% of women and 27% of men reported a need for
help in the last month with one or more activities of daily
living (ADLs) such as getting up and down stairs, dressing,
getting around indoors, or shopping [10]. These people
are in transition from independence to frailty and have a
great deal to gain if loss of function can be reversed and
independence maintained.
Sedentary behaviour and mobility limitations in older
people are more prevalent in socio-economically deprived
sectors of the population [11]. Ethnically diverse groups in
the USA have a significantly greater risk of a range of
physical and mental health problems compared to their
White counterparts, and subsequently suffer higher rates of
morbidity and premature mortality [12]. Self-reported data
from the HSE indicate that older (55 + years) Bangladeshi,
Pakistani and Indian adults in England are less likely to
meet physical activity guidelines compared to their White
European counterparts [10]. Thus, exercise interventions
that can successfully engage and retain sedentary and
ethnically diverse groups of older adults could contribute to
the reduction of health inequalities.
Lifestyle Interventions and Independence for Elders
(LIFE) is a landmark study in the field of physical activity
promotion in older adults [8]. LIFE was a multi-centre
randomised controlled trial comparing the effects of a
physical activity programme with a successful ageing
educational programme in more than 1600 functionally
impaired older persons, over an average follow-up of 2.
6 years. The intervention reduced the risk of developing
major mobility disability (defined as the inability to
complete a 400-m walk test within 15 min) [8] by 18%
relative to the control group (Hazard Ratio (HR) 0.82: 95%
confidence interval (CI), 0.69–0.98). It also reduced the
risk of persistent mobility disability by 28% (major mobil-
ity disability at consecutive time points) (HR 0.72; 95% CI,
0.57–0.91). The intervention group maintained an
increase of 40 min/week (95% CI, 29 to 52; p < .001) in
objectively assessed lifestyle-intensity activity (≥ 760
counts/min compared with the control group at
24 months of follow-up). These estimates are likely to be
conservative as the study utilised an active control group
which received a substantial health education/lifestyle
intervention including weekly workshops for 6 months
and monthly sessions for a further 18 months.
Building on the success of the LIFE study in the USA, the
REtirement in ACTion (REACT) study aims to test the
effectiveness and cost-effectiveness of a community-based
physical activity intervention for reducing, or reversing, the
progression of functional limitations in older people who
are at high risk of mobility-related disability.
Methods
Trial design
The study protocol is presented in accordance with the
Standard Protocol Items: Recommendations for Interven-
tional Trials (SPIRIT) guidelines (Additional files 1 and 2).
The REACT study is a multi-centre, pragmatic, two-
arm, parallel-group randomised controlled trial with an
internal pilot phase and that incorporates comprehensive
process and economic evaluations. Following identifica-
tion and recruitment, 768 participants who meet the
study inclusion criteria will be randomised to receive
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either the REACT intervention, delivered over a period
of 12 months by trained facilitators or a minimal control
intervention. The pilot phase will assess the feasibility of
recruitment methods (allowing for some refinement if
needed) and confirm adequate retention rates in the
intervention and the study, prior to progressing with the
main trial. A nested sub-study, led by the Wellcome
Centre for Integrative Neuroimaging, University of
Oxford, employing magnetic resonance imaging (MRI),
will test the hypothesis that the REACT intervention will
slow the rate of brain atrophy and of decline in cognitive
function. Outcome data will be collected at baseline, 6,
12 and 24 months for the main study, with MRI sub-
study data collected at baseline, 6 and 12 months. The
REACT study was reviewed and approved by the
National Health Service (NHS) South East Coast-Surrey
Research Ethics Committee (15/LO/2082). The study is
registered as a current randomised controlled trial
(ISRCTN45627165).
The REACT study will be conducted at three UK sites
– Bath/Bristol, Devon and Birmingham – allowing re-
cruitment of a socio-economically and ethnically diverse
sample including participants from urban, rural and
semi-rural locations.
Study population
The eligibility criteria are intended to identify 768 sed-
entary, community-dwelling, older people aged 65
years and over with functional limitations (i.e. who are
at risk of major mobility limitations), but who are still
ambulatory, i.e. they can still walk. This will be mea-
sured using a battery of objective physical function
tests (Short Physical Performance Battery (SPPB)) to
assess balance, walking speed and the ability to change
from a sitting to a standing position. This generates a
physical function score from 0 to 12 older adults with
scores of 4–9 (inclusive) out of 12 will be eligible to
take part in REACT. This is based on data showing
that older adults with SPPB scores of 9 or less have
substantially higher risk of major mobility disability 3
years later (odds ratio (OR) = 8.3 (95% CI, 3.3 to 20.
67) compared with those with a score of 12 [8, 13].
Inclusion and exclusion criteria are summarised in
Table 1.
Recruitment
A range of recruitment strategies to identify suitable par-
ticipants will be employed:
Table 1 Eligibility criteria for participation in the REACT study and the magnetic resonance imaging (MRI) sub-study
Inclusion criteria Aged 65 years or older and not in full-time employment
Planning to reside in the target area (Bath/Bristol, Devon, Birmingham) for at least 24 months
Score between 4 and 9 (inclusive) on the Short Physical Performance Battery (SPPB)
Exclusion criteria Self-reported inability to walk across a room without a walker or the help of another person
Existing major mobility limitation (defined as SPPB of 3 or less, or unable to complete the 4-m walk component of SPPB)
Living in residential or nursing care
Inability to attend the REACT physical activity sessions as scheduled
A documented or patient-reported medical condition that would preclude participation, including:
• Arthritis so severe it would prevent participation in physical activity
• Parkinson’s disease or diagnosed dementia
• Any terminal illness
• Lung disease requiring use of orally administered corticosteroids or supplemental oxygen
• Severe kidney disease requiring dialysis
• Severe heart disease that would prevent participation in physical activity (e.g. chest pain when walking 100 or 200 yards or
up a flight of stairs)
• Implanted cardiac defibrillator
• Cardiac arrest which required resuscitation
• Severe uncontrolled psychiatric illness
• Currently receiving radiation therapy or chemotherapy treatment for cancer
• Awaiting knee or hip surgery
• Major heart surgery (including valve replacement or bypass surgery) in the last 6 months
• Unstable heart condition (e.g. uncontrolled arrhythmia, angina, heart failure or hypertension)
• Spinal surgery in the last 6 months
• Any other clinical condition that the person’s GP or clinician considers would make them unsuitable for participation in a
physical activity rehabilitation programme to prevent decline of lower-limb functioning
For the MRI sub-study:
Contraindications for MRI scanning (assessed using CRIC Bristol Standard Operating Procedure for Screening Subjects for Safety
to Scan (Ref MRI Local Rules and Procedures, 2011)
History of neurological illness (e.g. stroke)
Current treatment for a psychiatric illness
Insufficient English to understand what participation entails and provide consent in English
Temporary exclusion
criteria
Heart attack (or myocardial infarction), stroke, spinal surgery, hip fracture, hip or knee replacement within the previous 6
months
Currently receiving physical therapy on legs or enrolled in another physical activity research or intervention study
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Primary care
General practitioner (GP) practices in the study catch-
ment areas will be invited to participate through their
local Clinical Research Network (CRN) and through
existing networks. Where possible we will select prac-
tices to maximise diversity in terms of ethnicity, socio-
economic status and (in Devon) rurality.
Practice staff will search the practices’ electronic patient
databases for potentially eligible patients using the trial
entry criteria (for criteria that are coded in the database).
Lists generated from the searches will be further screened
for suitability by a GP at each practice particularly to
screen for items that are not included (or can only be
partially covered) by the electronic searches. A Patient
Approach Letter printed on the practice headed note-
paper, a reply form and Participant Information Sheet
(PIS) will be sent to suitable patients, with a reply paid
envelope addressed to the research team at the local trial
site. If the target recruitment rate is not achieved,
practices will be asked to send out follow-up Participant
Approach Letters to the same patients 14–21 days later.
GPs and practice nurses may also offer the recruitment
pack in surgery to patients who they consider would fit
the REACT recruitment criteria.
Third-sector organisations
The principal investigators at each trial site will engage
with third-sector and community-based organisations and
authorities which work with adults over the age of 65
years. Professionals in these services will either approach
potentially eligible service users and provide a brief sum-
mary of the study or invite the study researchers to give a
presentation about the study, followed by provision of the
Participant Approach Letter and PIS, if deemed appropri-
ate. Publicity materials will be made available through
libraries, supermarkets, post offices and GP surgeries.
Word-of-mouth and snowball sampling
To enhance recruitment, we will use word-of-mouth and
snowball sampling techniques and employ the assistance
of bi-lingual community champions. This approach will
be particularly useful for engaging with ethnically diverse
groups.
Local media
Recruitment will be supported by a low-cost public rela-
tions campaign targeting local newspapers, magazines,
radio and community events.
Each REACT trial site will track recruitment methods to
determine the most successful strategy for recruiting and
for recruiting from diverse ethnic groups in particular.
Eligibility screening
The eligibility of respondents will be assessed in a three-
step sequential screening process:
1. Initial self-selection: the Participant Approach
Letters and PIS will make it clear that we wish
to recruit people who are still able to complete
but have some difficulty with daily activities
such as walking, climbing stairs and getting
out of a chair
2. Telephone-based screening: after gaining verbal
consent a preliminary telephone screen will check
inclusion and exclusion criteria that can be assessed
by telephone (e.g. self-reported inability to walk
across a room), including a second check on medical
exclusion criteria (e.g. recent heart surgery). Ability
to attend intervention sessions will also be checked.
Participants who do not meet the eligibility criteria
will be thanked for their time and provided with an
information pack including the Age UK/NHS guide
to Health Ageing and sources of further advice and
information
3. Face-to-face screening sessions: potentially eligible
participants will then be invited to a group-based
assessment session where they will have an opportunity
to ask questions about the study and be asked to
give written informed consent. The SPPB Gait
Speed Test will be conducted first, and those who
fail to complete the 4-m walk, or do not meet the
other SPPB inclusion criteria, will be thanked for
their time and provided with an information pack
(as above). Participants who meet the eligibility
criteria will be invited to complete the remainder
of the baseline assessments
4. MRI sub-study: REACT participants who consent
to discuss participation in the MRI sub-study will
be screened for exclusion criteria using the CRIC
Bristol SOP Screening Subjects for Safety to Scan
[14]. This will be repeated immediately before the
MRI scan
Consent
Older adults who are willing to take part in REACT will
be asked to provide written informed consent prior to
commencement of the face-to-face screening sessions.
The consent process will involve a brief recap of the PIS
and an opportunity to ask questions prior to any of the
face-to-face screening/baseline data collection processes
commencing. Potential participants will be informed that
they may, at any time, withdraw their consent to partici-
pate in the study without giving a reason, and without it
affecting their relationship with their GP or the referring
organisation and/or their future treatment and care.
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Randomisation/allocation
When 30 eligible participants have been recruited (enough
to form one study group) they will be randomised to one
of the two arms (physical activity (intervention) arm or
social and education (control) arm using a secure, centra-
lised, web-based randomisation website built by Peninsula
Clinical Trials Unit (CTU). Randomisation will be per-
formed using a minimisation algorithm to balance groups
in terms of study site (Bath/Bristol, Birmingham, Exeter/
Devon), age group, gender and initial functional ability
(SPPB score). This algorithm has been built by the Penin-
sula CTU and uses the method proposed by Taves and
extended by Pocock et al. [15, 16]. It maintains a stochas-
tic element by computing probabilities proportional to the
existing imbalance at the point of randomisation.
During the pilot phase, the randomisation will be 2:1
(intervention/control) in order to enable feasibility testing
of intervention engagement and retention as early as
possible. The main trial randomisation will be 1:1. Couples
presenting together at the screening where both people
are eligible and willing to be involved in the study will be
randomised together to reduce contamination between
study arms.
Study intervention
The primary aim of the REACT study is to assess the effect-
iveness of a community-based physical activity intervention
for reducing the progression of mobility-related functional
limitations in older people who are at high risk of transition
from independence to mobility-related disability.
Intervention arm
The intervention group will receive a standardised 12-
month exercise programme designed for delivery in
leisure/community centres where low-cost off-peak
capacity is available. REACT will be delivered by quali-
fied exercise professionals with experience of leading
exercise classes in the community. We will collaborate
with existing community-based organisations who have
access to suitable venues and delivery staff. Sessions will
be organised as group activities with up to 15 partici-
pants per group, but there will be individually tailored
elements for aerobic exercise, strength work and exercise
progression plans. Activities will include cardiovascular,
strength, balance and flexibility exercises and daily
lifestyle-based activity in the form of neighbourhood
walking and active travel. Breaks in sedentary time will
also be promoted. Social activities, such as post-exercise
coffee meetings and community-based activities, will be
organised to encourage a ‘social club’ atmosphere, pro-
mote long-term compliance and contribute to social
well-being.
The intervention sets a long-term target for partici-
pants of 150 min of moderate-intensity activity per
week, which is approached progressively. ‘Home-
friendly’ exercises and written materials will be supplied
to encourage participation in exercise in the home envir-
onment [17]. If participants miss two consecutive
sessions, REACT leaders will telephone the participant
to problem-solve ways for the participant to re-engage
with the programme.
One novel element is the accompanying ‘REACT
ambassadors’ scheme that provides the opportunity for
participants to develop expertise and contribute as a
local neighbourhood coordinator, or in other volunteer-
ing roles, determined by the provider. Our aim is to pro-
duce a pragmatic model of delivery that is rooted in the
needs of the local community, that attracts a diverse
population of older adults, is increasingly self-sustaining,
and that has potential for application across the UK.
REACT will be delivered in two progressive phases
(adoption and maintenance) and established behaviour-
change techniques will be used to enhance motivation,
to make realistic plans for sustainable activity, to pre-empt
and overcome barriers, to engage social support and to
use self-monitoring and self-regulatory techniques to
support the maintenance of behaviour change. The
REACT co-applicants will provide training in intervention
delivery methods, including detailed session plans to
ensure consistency in, and fidelity to, programme delivery.
Start up (adoption: weeks 1–8): the purpose of this
phase is to stimulate initial increases in physical activity
and fitness, to reduce any anxieties or concerns about
exercise, and to build confidence and a sense of attach-
ment to the programme. Each participant will receive a
45-min individualised, face-to-face introductory session
which will be used to personalise the programme for
starting levels and progression. Two 60-min physical
activity sessions per week, plus 15–20 min of social time,
will then be delivered by the REACT trainer.
Build up (adoption: weeks 9–24): a 45-min interactive
educational/social session run by the REACT trainers
will be added at the end of one of the two weekly
sessions. These sessions will use evidence-based, person-
centred behaviour-change strategies to build intrinsic
motivation and self-efficacy. They will be designed to
maximise enjoyment, social interaction and group identity
[18]. Behavioural management will focus on self-regulation
using goal setting, self-monitoring, reviewing of goals and
problem-solving [19, 20]. A key focus will be on exploring
and planning transition to more lifestyle-based activities.
Pedometers will be introduced during these sessions to
support the participant in the transition to the maintenance
phase. After week 12, the exercise session frequency will be
reduced to one per week but with an expectation that
participants find an hour per week to exercise at home, in
the neighbourhood or at a physical activity session in their
local community. Participants will also be introduced to the
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REACT Ambassador training programme which will be
delivered during the maintenance stage.
Taking charge (maintenance: weeks 25 to 52): the
maintenance stage will focus further on home and
neighbourhood-based activities while continuing with a
weekly centre-based physical activity session followed by
a short social session. Participants will enact action plans
for physical activity outside of the REACT programme
that were made during the transition phase and will be
supported through group social/education meetings
once a month. We will encourage groups to self-
organise their own social interaction beyond the scope
of the study and to consider doing activities together.
Participants will be informed about local opportunities
for physical activity in their community.
All intervention group participants will be offered the
opportunity to be trained as REACT Ambassadors to help
support the long-term sustainability of the programme.
REACT Ambassadors will primarily focus on becoming
local community activators facilitating local physical activity
opportunities. This will help to increase maintenance activ-
ities and increase the frequency of meetings in the mainten-
ance stage without adding to intervention costs.
Post intervention: REACT Ambassadors will help to
sustain activities after the initial 12 months by organising
group meetings and activities, and participants may be
offered the weekly REACT sessions at a subsidised rate
(subject to agreement with providers). The Ambassador
programme is, therefore, designed to promote growth and
increase sustainability.
Control arm
After completion of baseline assessments, participants
allocated to the control group will be given information
regarding healthy ageing. They will be invited to three 60–
90-min group sessions over the 2 years of the study. These
will consist of presentations and discussion groups on
various aspects of healthy ageing (excluding physical activity)
and incorporate socialising opportunities.
Intervention delivery
The REACT intervention sessions will be delivered at
leisure or community centres provided by REACT collab-
orators during low-usage hours in economically and
ethnically diverse areas in Bath, Bristol, Devon and
Birmingham. REACT trainers will be qualified to at least
Register of Exercise Professionals (REPS) Level 3 (Exercise
Referral Diploma or equivalent) and will be experienced in
delivering safe and effective exercise sessions to older
adults. Social/education sessions may be delivered by
other staff from the same organisation. All staff will attend
a 2-day, standardised training workshop on the delivery of
the REACT exercise and social/education sessions, based
on a written programme of materials and manuals.
Intervention fidelity
We will include a range of the strategies outlined by the
NIH Behaviour Change Consortium to reinforce interven-
tion fidelity [21]. We will: (1) ensure ‘design fidelity’ by
building our intervention around a clear logic model
(Additional file 3: Figure S1); (2) recruit REACT trainers
with appropriate skills and experience; (3) develop an ac-
cessible, standardised intervention manual; (4) implement
the standardised REACT trainer training programme; (5)
train more REACT trainers than needed to accommodate
illness or withdrawal; (6) monitor delivery fidelity via
recording of consultation meetings for a sample of three
to four sessions per intervention provider and the applica-
tion of a fidelity checklist: and (7) check for intervention
‘receipt’ and ‘enactment’ of appropriate levels of physical
activity outside of the REACT sessions by including
opportunities to check participant understanding of the
correct performance of exercises and regularly review
progress in the social-educational sessions. In addition,
fidelity will be enhanced by incorporating a gradual transi-
tion to daily activity within the structure of the REACT
intervention (i.e. withdrawal of one session per week after
12 weeks, reduction of social sessions to once/month after
the first 6 months, with targeted planning of ongoing
lifestyle-based physical activities around each transition).
Intervention theoretical framework
The REACT social and educational programme draws on
two overlapping and mutually compatible theoretical per-
spectives, Social Cognitive Theory and Self Determination
Theory. These theories provide the main principles and
processes for supporting behaviour change [22, 23]. The
Skills for Maintenance (SkiM) model has also been used
to identify additional processes and techniques to promote
maintenance of physical activity [24]. For further detail
see the REACT logic model (Additional file 3: Figure S1).
Assessments
A full list of measures and time points is presented in
Table 2. The person conducting the assessments will
check for completion of questionnaires before participants
leave the assessment premises, and will make every effort
to ensure that missed or spoiled questions are addressed.
Sample size calculation
The primary aim is to assess the long-term (2 years) effect
of a physical activity intervention on SPPB scores. A change
of 0.5 points has been defined as a minimum meaningful
change in SPPB score and 1 point is considered a substan-
tial change [8, 25]. Based on data from the LIFE and LIFE-
P studies, a difference between groups of 0.5 to 0.6 points
in change in SPPB scores is feasible at 12 months and at
3 years. In the LIFE study, the standard deviation for the
change in SPPB scores from baseline to 2 years was 2.2 and
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Table 2 REACT schedule of assessment
Visit type Scr11 Scr22 FU33 FU44 FU55
Visit code SV1 F06 F12 F24
Visit number 1 2 3 4
Telephone call 1
Activity/assessment month − 0.5 0 6 12 24
Form name
Verbal consent X
Telephone screening (some elements of inclusion and exclusion criteria) (see Additional file 4) X
Written informed consent (see Additional file 5) X
Contact information update X X X X X
Demographic, social, economic X
SPPB battery (see Additional file 6 for full CRF) [12] X X X X
Accelerometry X X X X
Height and weight X X X
MoCA – Montreal Cognitive Assessment [13] X X X X
PASE questionnaire [14] X X X X
Dynometer (hand-grip strength) X X X X
Ageing Well profile (two sites full scale, one site social well-being scale only) [15] X X X
Health-related quality of life (EQ-5D-5 L, SF-36) [16, 17] X X X X
Sleep Condition Indicator [18] X X X
Pain (Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) [19] X X X
Mobility Assessment Tool-short form (MAT-sf) [20] X X X X
Cognitive function (UK Biobank Healthy Minds Questionnaire) [21] X X X X
Medical history including medications, chronic diseases, cardiovascular disease and other conditions X
Falls Inventory including falls in last 6 months and injuries relating to falls X X X X
Health and Social Service Usage including use of primary, secondary or community care services in previous 6 months X X X X
(MRI sub-study) MRI scan, detailed cognitive assessment and gait analysis X X X
Process evaluation6 X X
Session attendance (intervention group only) X X
Total contact time for each participant X X X
Physical activity related self-concept X X X
Perceived tension of maintaining current PA X X X
Perceived tension of maintaining current exercise X X X X
Autonomy in relation to PA X X X X
Competence for PA X X X X
Relatedness for PA X X X X
Enjoyment of PA X X X X
Perceived intrinsic benefits of PA (social, physical and emotional)
Autonomy for strength-building exercise X X X X
Competence for strength-building exercise X X X X
Relatedness for strength-building exercise X X X X
Enjoyment of strength-building exercise X X X X
Perceived intrinsic benefits of strength-building exercise (social, physical and emotional) X X X X
Enjoyment of the REACT programme (intervention group) X X
Credibility/identification with the session facilitators (intervention group only) X X
1Telephone screening, 2Face-to-face screening (baseline assessment), 36-month follow-up, 412-month follow-up, 524-month follow-up. 6Bespoke or adapted
questionnaire developed for the REACT study. Full details of the process evaluation will be reported in detail elsewhere. The questionnaires are provided in
Additional file 6
Abbreviations: CRF Case Report Form, MRI magnetic resonance imaging, PA physical activity, SPPB Short Physical Performance Battery test
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in the OPAL Plus UK-based study the standard deviation
for change in SPPB over three years was 2.0 for participants
with a baseline SPPB score of 8 or less. We have also
assumed a two-sided significance level of 0.05 and that loss
to follow-up will accumulate at 12.5% per year throughout
the 2-year follow-up period of REACT.
To detect a between-groups difference of 0.5 points in
SPPB change scores with a standard deviation of 2.0, with
loss to follow-up at 12.5% per year, the required sample
size is 384 per arm for 85% power using two sided 5%
significance. The REACT study will therefore look to
recruit a total sample of 768 participants. This sample size
also provides 90% power to detect a difference in moderate
intensity physical activity of 50 min per week (standard
deviation (SD) 185 min/week) with significance at p = 0.05.
Statistical analysis
Primary outcome analysis will be undertaken blinded to
group allocation. Primary comparative analyses will be on
an intention-to-treat (ITT) basis with due emphasis placed
on confidence intervals. Using appropriate descriptive
statistics, we will assess any imbalance between the trial
arms at baseline and describe the characteristics of partici-
pants. The comparison of primary interest is the difference
between the intervention and the control arm on SPPB
score at the 2-year follow-up. This will be presented as
between-group differences in means, 95% CIs and p values.
Covariates in the model will comprise of baseline SPPB
scores, centre, age group and gender.
Depending on the extent of missing primary outcome
data, the primary analysis will be repeated using the
complete data set generated using multiple imputations.
Sensitivity analyses will be conducted to investigate the
potential effects of missing data and of any co-interventions
on the conclusions.
Secondary outcome analysis will be undertaken using
the same general approach as for the primary analysis,
using the baseline, 6-month, 1-year and 2-year follow-up
data. This will include linear or logistic regression models
for continuous or binary outcomes as appropriate.
Subgroup analyses
We will compare the primary outcome between sub-
groups characterised by: (1) high vs. low adherence; (2) co-
morbidity levels (one or less known chronic medical
conditions vs. multiple co-morbidities); (3) socio-economic
subgroups (using education, housing type and postcode),
age categories (65–74 years and 75 + years); (4) gender and
REACT site (Bath/Bristol, Devon, Birmingham) and (5)
fallers and non-fallers (in 6 months prior to baseline).
Adjusted analysis
Using appropriate descriptive statistics, we will assess any
imbalance between the trial arms at baseline and describe
the characteristics of participants. As participants are
randomised using the method of minimisation we are not
expecting significant imbalance between groups. However,
the minimisation variables (age, gender, SPPB) will be
adjusted for in the statistical analysis.
MRI imaging sub-study
Primary and secondary outcome data analysis
The primary analysis will be based on an intention-to-
treat (ITT) principle. The primary outcome (change in
adjusted hippocampal volume) will first be examined
using a one-way analysis of variance (ANOVA) with group
(exercise, control) as a between-subjects factor. An ana-
lysis of covariance (ANCOVA) model will then be carried
out with the primary outcome as output, group as main
factor, and age group, gender and education as covariates.
If there is a main effect of group, single-sample t tests will
be conducted to assess whether the rate of change in
hippocampal volume differed from 0.
The secondary cognitive and behavioural outcomes will
also be modelled using ANCOVAs. For the MRI secondary
outcomes, specialised neuroimaging techniques, including
non-parametric methods, will be employed. To examine
the correlations between change in hippocampal volume
and change in relational memory, Pearson’s correlations
will be calculated.
Data presentation and analysis models
Continuous outcomes will be summarised by means and
SDs (or medians and interquartile ranges (IQRs) if distribu-
tions are skewed). Categorical outcomes will be presented
as numbers and percentages of patients in each category.
Binary outcomes will be presented as numbers and percent-
ages of patients in the category of interest.
Model assumptions
For all methods outlined, underlying assumptions will be
checked using standard methods, e.g. residual plots. If
assumptions are not valid then alternative methods of
analysis will be sought. In particular, the underlying
assumption of the linear impact of baseline covariates will
be assessed and, if necessary, baseline covariates will be
categorised and fitted as factors in the model. Age, gender
and SPPB will be adjusted for in the statistical analysis.
Subgroup analyses
We will compare response to exercise based on SPPB score
(ranges 4–7 and 8–9), adherence (high-low), age categories
(65–74, 75 + years), gender and cognition (MoCA < 26 >
26, 26 + years).
Economic evaluation
The economic evaluation will estimate the cost-effectiveness
of the REACT intervention compared to control, for older
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people with major mobility limitations, from the perspective
of the NHS and Social Care Services.
Using data collected within trial we will estimate the
resource use and costs associated with delivery of the
intervention, and the wider NHS-, social care- and
participant-level resource use and costs over a 24-month
follow-up. The primary component of resource use for
delivery of the intervention is the time input (contact and
non-contact time) for REACT trainers, and data will be
collected on each activity by the trainer over the delivery
of the intervention for each group, and across each phase
of intervention delivery. Other areas of resource use (e.g.
training, set-up, facility costs, cost of pedometers) will be
recorded within trial by the trial coordinator. Data on use
of health-, social care- and other participant-related re-
source use will be collected, using a participant self-report
resource use questionnaire, at baseline, 6, 12 and 24
months. Data on resource use will be combined with
national unit cost data obtained from available sources
including Personal Social Services Research Unit (PSSRU)
and NHS reference costs to estimate costs over the 24-
month follow-up [26, 27]. The primary economic out-
come measure will be the quality-adjusted life years
(QALYs) derived from participant-reported EuroQoL five-
dimension, five- level (EQ-5D-5 L) data, applying the
area-under-the-curve approach [28], collected alongside
the resource use questionnaire and using the UK tariff
(presently recommended by NICE [29]). Data on estimated
costs and QALYs by group will be presented, together with
incremental QALYs and incremental costs, to present a
policy-relevant cost-effective analysis (CEA).
Analysis will follow established methods for the con-
duct of economic evaluation in health technology assess-
ment [30] and will be consistent with recommendations
from NICE (UK) on ‘reference case’ cost-effectiveness
analyses [31]. Findings will be reported in keeping with
the CHEERS guidelines for cost-effectiveness studies
[32]. CEA will be presented using base case estimates
and uncertainty will be considered via detailed one-way
and multi-way sensitivity and scenario analyses. The
non-parametric nature of the distribution of resource
use and cost data will be addressed using bootstrapping
methods for estimation of confidence intervals around es-
timates of mean costs and incremental cost-effectiveness
ratios (ICER). Results will include disaggregated data, as
well as synthesis of costs and outcome data, and will
include presentation of cost-effectiveness plane and cost-
effectiveness acceptability curves to describe the likelihood
of cost-effectiveness at different cost-effectiveness thresh-
olds [33, 34].
To address missing data on costs and outcomes, multiple
imputation will be used for making the assumption that the
data are missing at random [35]. Given the longer-term
nature of potential benefits from the REACT intervention,
we will conduct evidence synthesis and decision-analytic
modelling to assess the longer-term (lifelong) consequences
of the intervention vs. control, including consequences in
terms of health and social care costs.
Process evaluation
The REACT process evaluation plan will follow the prin-
ciples of the UK Medical Research Council guidance on
process evaluation [36]. A full protocol for process
evaluation is in development and will not be reported in
detail here. However, the aims and methods are briefly
summarised below. The purpose of the REACT process
evaluation is to:
 Evaluate the feasibility of implementation,
including barriers and facilitators, to inform
future implementation and possible refinements
of the intervention
 Evaluate the quality and quantity of intervention
delivery to inform conclusions about intervention
effectiveness
 Investigate the proposed mechanisms of change,
outlined in the REACT logic model (Additional file 3:
Figure S1) and seek alternative explanations if this
model is not supported
 Understand the role of context to inform whether
and how the findings can be generalised
Methods used in the process evaluation will include:
1. A mixed-methods assessment of intervention
fidelity (quality of intervention delivery). This
will include application of an intervention fidelity
checklist to audio-recordings of a purposive
sample of intervention sessions. This will generate
a descriptive summary of delivery-quality scores.
Each item will be scored using the Dreyfus
competence-rating scale [37]. It will also generate
a qualitative summary of the recorded sessions,
highlighting examples of theorised and non-theorised
intervention processes in practice, as well as examples
of good and poor delivery. This analysis will help to
interpret and contextualise the data on intervention
adherence and effectiveness, providing explanations
about why the intervention might work better for
some people than others and what were the barriers
to engagement with the intervention
2. A qualitative analysis of data to examine processes
of change and elicit explanations for possible
intervention success or failure. This will integrate
data from: (1) semi-structured, longitudinal, individual
interviews at 6, 12 and 24 months with a purposive
sample of 24 participants in the intervention group
(designed to sample diversity in terms of SPPB scores,
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session attendance, ethnicity, age, gender, service
provider and area deprivation index) and (2) exit
interviews at 24 months with a sample of participants
and exercise leaders (after intervention completion).
Topic guides will be piloted with the REACT service
user advisory group prior to use. The analysis will
capture individual narratives/within-person processes
of change, as well as drawing out common themes.
Emergent themes will be compared and contrasted
with the theorised processes of change specified in
the logic model. Processes of engagement with the
intervention will also be explored. Using data
collected at 12 and 24 months, factors influencing
maintenance of physical activity/exercise will be
assessed and linked to responses at 6 months. This
will allow a qualitative description of participants’
experiences, potential pathways and barriers to
maintenance. Techniques to enhance the objectivity
and depth of the analysis may include cross-tabulation,
negative case analysis and hypothesis testing, as well as
respondent validation. Service users will also be
involved in the interpretation of the data through
workshops to discuss transcripts and the researchers’
interpretations of the data
3. Quantitative testing of hypotheses derived from
the logic model. For example, we hypothesise that
measures of theoretical determinants of behaviour
change will change more in the intervention arm
than in controls (between-group comparisons)
and that these changes will be associated with
between-group effects on physical activity
(mediation analyses). Brief questionnaires assessing
mechanisms of change suggested by Social
Cognitive Theory and Self-Determination Theory
(the main theoretical underpinnings of the
intervention model) will be administered at baseline,
6, 12 and 24 months (see Table 2 and Additional file 6).
We will also investigate the mediating and moderating
effects of changes in physical activity on the primary
outcome (physical function) and other outcomes of
interest (cognitive function, sleep quality, well-being,
depression) using multiple regression models
Discussion
Breaking the spiral of decline that is characterised by loss
of physical and cognitive function, reduced capacity to
independently manage daily tasks and reductions in social
interaction is fundamental to healthy ageing. It also has
the potential to substantially reduce reliance on health
and social care services as people grow older. This is par-
ticularly true for those who are at risk of mobility-related
disability resulting from low levels of physical activity as
they settle into changed routines after their primary work-
ing years. Strong clinical evidence supports the role of
physical activity in reducing or even reversing this decline
[8]. However, there have been few attempts to develop,
and rigorously evaluate, feasible models of physical activity
promotion for older people in community settings. In par-
ticular, there are no programmes that specifically target
people at high risk of mobility-related disability, and few
programmes are grounded in service-user and service-
provider perspectives [38].
REACT represents the first large-scale, pragmatic,
community-based trial in the UK to target the non-disabled
but high-risk segment of the older population with an
intervention to reduce mobility-related disability. This
approach has many advantages. People in this category are
still physically capable of engaging in a progressive exercise
programme and have potential for prevention of further
physical decline. A programme that can successfully engage
them in sufficient activity to improve strength, aerobic
capacity, coordination and balance would have a major
impact on their prospects for sustained health and inde-
pendence [8].
REACT is also the first study of its kind to conduct a full
economic and comprehensive process evaluation alongside
the RCT. These elements will test the effectiveness and
cost-effectiveness of the REACT intervention, as well as
build a deeper understanding of crucial mechanisms for (1)
generating physiological and mental health benefit in this
population and (2) promoting sustained change in physical
activity. The MRI sub-study will provide significant
advancements in the neuroscientific literature, adding com-
prehensive data on the impact of physical activity and func-
tional ability on brain volume and cognitive function in
later life.
If effective and cost-effective, the REACT intervention
has strong potential to be implemented widely in the
UK and elsewhere. The REACT study is likely to inform
UK and international healthy ageing guidance and health
promotion policies for the prevention of disability and
the maintenance of independent living in older adults.
Trial status
Enrolment into the study started in March 2016. Recruit-
ment is expected to be completed by 31 October 2017
and final follow-up assessments by 30 November 2019.
Additional files
Additional file 1: Completed SPIRIT (2013) Checklist detailing on which
page of the protocol manuscript each of the relevant recommended
items is addressed. (DOC 123 kb)
Additional file 2: Additional detail from the REACT Trial Protocol
relating to the SPIRIT 2013 Checklist (Additional file 1). (DOC 117 kb)
Additional file 3: REACT process evaluation protocol and Logic model.
(DOCX 128 kb)
Stathi et al. Trials  (2018) 19:228 Page 10 of 12
Additional file 4: REACT Telephone Screening Form used to collect
demographic data and undergo and initial eligibility assessment with
potential participants. (DOCX 149 kb)
Additional file 5: REACT Participant Consent Form. (DOCX 135 kb)
Additional file 6: REACT Case Report Form including all measures and
items used to collect outcome data as described in Table 2. (DOC 1427 kb)
Abbreviations
AE: Adverse event; CEA: Cost-effective analysis; CI: Chief investigator;
CRF: Case Report Form; CRN: Clinical Research Network; CTU: Clinical Trials
Unit; DMEC: Data Monitoring and Ethics Committee; EC: European
Commission; EU: European Union; EUCTD: European Clinical Trials Directive;
EudraCT: European Clinical Trials Database; GCP: Good clinical practice;
IB: Investigator Brochure; ICER: Incremental cost-effectiveness ratios;
ICF: Informed Consent Form; IDMC: Independent Data Monitoring
Committee; ISF: Investigator Site File; ISRCTN: International Standard
Randomised Controlled Trials Number; ITT: Intention-to-treat; MRI: Magnetic
resonance imaging; MVPA: Moderate to vigorous physical activity; NHS
R&D: National Health Service Research and Development; PI: Principal
investigator; PIC: Participant Identification Centre; PIS: Participant Information
Sheet; QALY: Quality-adjusted life year; RCT: Randomised controlled trial;
REC: Research Ethics Committee; SAE: Serious adverse event; SPIRIT: Standard
Protocol Items: Recommendations for Interventional Trials guidelines;
SPPB: Short Physical Performance Battery; TMF: Trial Master File; TMG: Trial
Management Group; TSC: Trial Steering Committee
Funding
This project is funded by the NIHR Public Health Research programme (13/164/
51). The views expressed are those of the authors and not necessarily those of the
NHS, the NIHR or the Department of Health. The MRI sub-study is supported by
the NIHR Oxford Health Biomedical Research Centre (BRC) and the NIHR Oxford
BRC based at Oxford University Hospitals NHS Trust and University of Oxford. The
Wellcome Centre for Integrative Neuroimaging is supported by core funding from
the Wellcome Trust (203139/Z/16/Z). HJB is supported by the Wellcome Trust
(110027/Z/15/Z). CES is supported by the Global Brain Health Institute.
Availability of data and materials
Not applicable.
Authors’ contributions
AS is responsible for the conception and design of the research methods,
procedures, intervention design, manuscript writing. JW is responsible for the
conception and design of the research methods, procedures, intervention
design, manuscript writing. CJG is responsible for the conception and design
of the research methods, procedures, intervention design, manuscript
writing. JLT is responsible for the conception and design of the research
methods, procedures, manuscript writing. GJT is responsible for the
conception and design of the research methods. AM-L is responsible for the
conception and design of the research methods, procedures, manuscript
writing. JB is responsible for the conception and design of the research
methods. CG is responsible for the conception and design of the research
methods, procedures, manuscript writing. SG is responsible for the conception
and design of the research methods and procedures. HJB is responsible for the
conception and design of the research methods, procedures, manuscript writing.
CES is responsible for the conception and design of the research methods,
procedures, manuscript writing. MW, JdK, JCB, SJM, ND and PS are responsible
for the conception and the design of procedures. JMG and WJR are responsible
for the conception and design of the research methods, procedures and
intervention design. KRF is responsible for the conception and design of the
research methods, procedures, intervention design, manuscript writing. All authors
read and approved the final manuscript.
Ethics approval and consent to participate
The study protocol has been conducted according to the Declaration of
Helsinki and has been approved by the National Health Service (NHS) South
East Coast-Surrey Research Ethics Committee (15/LO/2082). The study is
registered as a current randomised controlled trial (ISRCTN45627165).
The consent process will involve a full explanation of the study given by
the person taking consent prior to any of the face-to-face screening
processes commencing. The verbal consent is read prior to the beginning
of the telephone screening interview. If the participant fails to give consent,
then a telephone screen will not be done. If a participant provides verbal
consent, then the assignment of a study ID number will be taken as positive
evidence that initial consent was obtained. Following these discussions
people who are willing to participate will be asked to complete, sign and
date the written Study Consent Form which will also be signed and dated
by the person obtaining consent. A copy of the signed Informed Consent
Form (ICF) will be given to the participant. The original signed form will be
retained in the relevant Investigator Site File (ISF).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department for Health, University of Bath, Claverton Down, Bath BA2 7AY,
UK. 2University of Exeter Medical School, St Luke’s Campus, Heavitree Road,
Exeter EX1 2LU, UK. 3School of Sport, Exercise and Rehabilitation Sciences,
University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. 4Faculty of
Health and Applied Sciences (HAS), University of the West of England (UWE
Bristol), Frenchay Campus, Coldharbour Lane, Bristol BS16 1QY, UK.
5Wellcome Centre for Integrative Neuroimaging, FMRIB, John Radcliffe
Hospital, University of Oxford, Oxford, UK. 6Wellcome Centre for Integrative
Neuroimaging, Oxford Centre for Human Brain Activity, Department of
Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.
7Department of Epidemiology and Public Health, University of Maryland,
School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201-1559,
USA. 8Department of Health and Exercise Science, Wake Forest University,
Worrell Professional Center 2164B, PO Box 7868, Winston-Salem, NC 27109,
USA. 9Centre for Exercise, Nutrition and Health Sciences, School for Policy
Studies, University of Bristol, Bristol BS8 1TZ, UK. 10Global Brain Health
Institute, Memory and Aging Center, Department of Neurology, University of
California San Francisco, San Francisco, CA, USA.
Received: 31 October 2017 Accepted: 14 March 2018
References
1. Gale CR, Cooper C, Aihie SA. Prevalence of frailty and disability: findings
from the English Longitudinal Study of Ageing. Age Ageing. 2015;44:162–5.
2. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people.
Lancet. 2013;381:752–62.
3. National Health Service. Social Care for Older Adults. Health Survey for
England 2016. https://digital.nhs.uk/catalogue/PUB30169.
4. Stathi A, Western M, de Koning J, Perkin O, Withall J. Implementing Physical
Activity Programmes for Community-Dwelling Older People with Early Signs
of Physical Frailty. In: Nyman S. et al. (eds) The Palgrave Handbook of
Ageing and Physical Activity Promotion. Cham: Palgrave Macmillan; 2018. p.
401–422.
5. Cooper R, Kuh D, Cooper C, Gale CR, Lawlor DA, Matthews F, Hardy R, the
FaHST. Objective measures of physical capability and subsequent health: a
systematic review. Age Ageing. 2011;40:14–23.
6. Simmonds B, Fox K, Davis M, Ku P-W, Gray S, Hillsdon M, et al.
Objectively Assessed Physical Activity and Subsequent Health Service
Use of UK Adults Aged 70 and Over: A Four to Five Year Follow Up
Study. PLoS ONE. 2014;9:5.
7. Giné-Garriga M, Roqué-Fíguls M, Coll-Planas L, Sitja-Rabert M, Salvà A.
Physical exercise interventions for improving performance-based measures
of physical function in community-dwelling, frail older adults: a systematic
review and meta-analysis. Arch Phys Med Rehabil. 2014;95:753–69.
8. Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, Espeland
MA, Fielding RA, Gill TM, Groessl EJ. Effect of structured physical activity on
prevention of major mobility disability in older adults: the LIFE study
randomized clinical trial. JAMA. 2014;311:2387–96.
Stathi et al. Trials  (2018) 19:228 Page 11 of 12
9. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing
and evaluating complex interventions: the new Medical Research Council
guidance. BMJ. 2008;337.
10. HSE: Health Survey for England. (Health Do ed., vol. 1); 2011.
11. Marmot MG, Allen J, Goldblatt P, Boyce T, McNeish D, Grady M, Geddes I.
Fair society, healthy lives: the Marmot ReviewSource: SCIE Social Care Online
- 01 January 2010. London: Marmot Review; 2010.
12. Centers for Disease Control and Prevention. Health Disparities and
Inequalities Report. Morb Mortal Wkly Rep. 2011;60:1–116.
13. Vasunilashorn S, Coppin AK, Patel KV, Lauretani F, Ferrucci L, Bandinelli S,
Guralnik JM. Use of the Short Physical Performance Battery Score to predict
loss of ability to walk 400 meters: analysis from the InCHIANTI Study. J
Gerontol Series A. 2009;64A:223–9.
14. Clinical Research and Imaging Centre UoB. MRI local rules and procedures
v1.1. Bristol 2014. https://www.bristol.ac.uk/media-library/sites/cricbristol/
documents/CRICBristol%20Quality%20Manual_ea_mastercopy_oct14.pdf.
15. Taves DR. Minimization: a new method of assigning patients to treatment
and control groups. Clin Pharmacol Ther. 1974;15:443–53.
16. Pocock SJ, Simon R. Sequential treatment assignment with balancing
for prognostic factors in the controlled clinical trial. Biometrics. 1975;31:
103–15.
17. Nelson ME, Layne JE, Bernstein MJ, Nuernberger A, Castaneda C, et al. The
effects of multidimensional home-based exercise on functional performance
in elderly people. J Gerontol. 2004;59:M154–60.
18. Ryan RM, Deci EL. A Self-Determination Theory approach to psychotherapy:
the motivational basis for effective change. Can Psychol. 2008;49:186–93.
19. Marcus BH, Forsyth LH. Motivating people to be physically active.
Champaign: Human Kinetics; 2008.
20. Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH,
Schwarz P. Systematic review of reviews of intervention components
associated with increased effectiveness in dietary and physical activity
interventions. BMC Public Health. 2011;11:119.
21. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M. Enhancing
treatment fidelity in health behavior change studies: best practices and
recommendations from the NIH Behavior Change Consortium. Health
Psychol. 2004;23:443–51.
22. Deci EL, Ryan RM. Handbook of self-determination research. Rochester: The
University of Rochester Press; 2002.
23. Bandura A. Health promotion from the perspective of social cognitive
theory. Psychol Health. 1998;13:623–49.
24. Greaves C, Poltawski L, Garside R, Briscoe S. Understanding the challenge of
weight loss maintenance: a systematic review and synthesis of qualitative
research on weight loss maintenance. Health Psychol Rev. 2017;11:145–63.
25. Perera S, Studenski S, Chandler JM, Guralnik JM. Magnitude and patterns of
decline in health and function in 1 year affect subsequent 5-year survival. J
Gerontol Ser A Biol Med Sci. 2005;60:894–900.
26. Curtis L, Burns A. Unit costs of health and social care 2016. Personal Social
Services Research Unit, University of Kent, Canterbury; 2016.
27. Department of Health: NHS reference costs 2015 to 2016. (Health Do ed);
2016. https://assets.publishing.service.gov.uk/government/uploads/system/
uploads/attachment_data/file/577083/Reference_Costs_2015-16.pdf.
28. Brazier J. Valuing health states for use in cost-effectiveness analysis.
PharmacoEconomics. 2008;26:769–79.
29. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd
A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the
EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708–15.
30. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW.
Methods for the economic evaluation of health care programmes. Oxford
University Press; 2015.
31. NICE. Guide to the methods of technology appraisal 2013. 2013. https://
www.nice.org.uk/process/pmg9/chapter/foreword.
32. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D,
Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health
Economic Evaluation Reporting Standards (CHEERS) Statement. Cost Eff
Resour Alloc. 2013;11:6.
33. Black WC. The CE plane: a graphic representation of cost-effectiveness. Med
Decis Mak. 1990;10:212–4.
34. Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-
effectiveness acceptability curves: an example using data from a trial of
management strategies for atrial fibrillation. BMC Health Serv Res. 2006;
6:52.
35. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in
cost-effectiveness analysis conducted within randomised controlled trials.
PharmacoEconomics. 2014;32:1157–70.
36. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L,
O’Cathain A, Tinati T, Wight D. Process evaluation of complex interventions:
Medical Research Council guidance. Br Med J. 2015;350:h1258.
37. Dreyfus SE. The five-stage model of adult skill acquisition. Bull Sci Technol
Soc. 2004;24:177–82.
38. Lubitz J, Cai L, Kramarow E, Lentzner H. Health, life expectancy, and health
care spending among the elderly. N Engl J Med. 2003;349:1048–55.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Stathi et al. Trials  (2018) 19:228 Page 12 of 12
